89 related articles for article (PubMed ID: 1745048)
1. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor.
Waymack JP; Flescher E; Venkatraman J; Fernandes G; Guzman RF; Yurt RW; Mason AD; Pruitt BA
J Surg Oncol; 1991 Dec; 48(4):239-45. PubMed ID: 1745048
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin E in multiple experimental models: V. Effect on tumor/host interaction.
Waymack JP; Chance WT
J Surg Oncol; 1990 Oct; 45(2):110-6. PubMed ID: 1976854
[TBL] [Abstract][Full Text] [Related]
3. The effect of elevated levels of thromboxane on host response to tumor.
Waymack JP; Fernandes G; Venkatraman J; Flescher E; Yurt RW; Guzman RF; Mason AD; Pruitt BA
J Surg Oncol; 1992 Jan; 49(1):3-9. PubMed ID: 1548878
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostaglandin E in multiple experimental models. IV. Effect on resistance to endotoxin and tumor necrosis factor shock.
Waymack JP; Moldawer LL; Lowry SF; Guzman RF; Okerberg CV; Mason AD; Pruitt BA
J Surg Res; 1990 Oct; 49(4):328-32. PubMed ID: 2214741
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
6. [Effect of the prostaglandin E produced by tumor cells on the enzymatic activity of adenosine metabolism and on human natural killer cytotoxic activity].
Umanskiĭ VIu; Kliuchareva TE; Matveeva VA
Eksp Onkol; 1989; 11(3):60-3. PubMed ID: 2546731
[TBL] [Abstract][Full Text] [Related]
7. The effect of PGE in multiple experimental models. II. Effect on steady-state levels of plasma and brain amino acids and transmitters.
Waymack JP; Chance WT; Nelson JL; Mason AD
Physiol Behav; 1989 Jun; 45(6):1201-5. PubMed ID: 2573094
[TBL] [Abstract][Full Text] [Related]
8. Effect of blood transfusions on immune function. Part VI. Effect on immunologic response to tumor.
Waymack JP; Fernandes G; Yurt RW; Venkatraman JT; Burleson DG; Guzman RF; Mason AD; Pruitt BA
Surgery; 1990 Aug; 108(2):172-7; discussion 177-8. PubMed ID: 2382219
[TBL] [Abstract][Full Text] [Related]
9. Effect of prostaglandin E on immune function in multiple animal models.
Waymack JP; Yurt RW
Arch Surg; 1988 Nov; 123(11):1429-32. PubMed ID: 3263107
[TBL] [Abstract][Full Text] [Related]
10. Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins.
Plescia OJ; Grinwich K; Plescia AM
Ann N Y Acad Sci; 1976; 276():455-65. PubMed ID: 1071971
[TBL] [Abstract][Full Text] [Related]
11. Effect of prostaglandin E in multiple experimental models. III. Effect on response to septic challenge.
Waymack JP; Mason AD
J Burn Care Rehabil; 1989; 10(6):481-5. PubMed ID: 2480961
[TBL] [Abstract][Full Text] [Related]
12. Effect of PGE in multiple experimental models. IX: In vivo effects of PGE on immune response of leucocytes to wounds.
Dong YL; Herndon DN; Yan TZ; Waymack JP
Burns; 1994 Apr; 20(2):132-5. PubMed ID: 8198717
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin E in multiple experimental models. VI. Effect on T-cell subsets.
Waymack JP; Guzman RF; Burleson DG; McManus AT; Mason AD; Pruitt BA
Prostaglandins; 1989 Sep; 38(3):345-53. PubMed ID: 2528784
[TBL] [Abstract][Full Text] [Related]
14. The influence of hepatocellular function on NK and T cell tumoricidal activity.
Roughneen PT; Kulkarni S; Kumar SC; Kulkarni AD; Fanslow W; Pellis NR; Rowlands BJ
Surgery; 1988 Nov; 104(5):888-93. PubMed ID: 2973140
[TBL] [Abstract][Full Text] [Related]
15. [Secretion of prostaglandin type E (PGE) by tumor cells of Syrian hamsters in in vitro contact with natural killers].
Kliuchareva TE; Matveeva VA; Bassalyk AS; Kushlinskiĭ NE
Biull Eksp Biol Med; 1988 Feb; 105(2):204-6. PubMed ID: 3349152
[TBL] [Abstract][Full Text] [Related]
16. Blood level of B and CD4+ lymphocytes measured before induction of an experimental tumor in rats predicts tumor progression and survival.
Demetrikopoulos MK; Goldfarb RH; Zhang ZB; Weiss JM
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):609-17. PubMed ID: 10868697
[TBL] [Abstract][Full Text] [Related]
17. Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages.
Prud'homme GJ; Fuks A; Colle E; Seemayer TA; Guttmann RD
J Exp Med; 1984 Feb; 159(2):463-78. PubMed ID: 6607315
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor metastasis by carrageenan-induced granulomas.
Kort WJ; Bijma AM; Hekking IM
Clin Exp Metastasis; 1989; 7(1):117-25. PubMed ID: 2908826
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
Santoli D; Zurier RB
J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
